B cell lymphomas express CX3CR1 a non-B cell lineage adhesion molecule

Cancer Letters

Volumn 259, Issue 2, 2008, Pages 138-145

  Andréasson, Ulrika ^a   Ek, Sara ^a   Merz, Hartmut ^b   Rosenquist, Richard ^c   Andersen, Niels ^d   Jerkeman, Mats ^e   Dictor, Michael ^e   Borrebaeck, Carl A K ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

^d Rigshospitalet   (Denmark)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Follicular lymphoma; Gene expression; Metastasis; Receptor

Indexed keywords

CELL ADHESION MOLECULE; CELL MEMBRANE PROTEIN; CHEMOKINE RECEPTOR CX3CR1; MEMBRANE RECEPTOR; MESSENGER RNA;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BREAST CANCER; CANCER GROWTH; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; FOLLICULAR LYMPHOMA; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; TISSUE SPECIFICITY; TUMOR CELL;

B-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, MANTLE-CELL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHEMOKINE; RNA, MESSENGER; TONSIL;

EID: 37049035312     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.031     Document Type: Article

References (19)

1. In: Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. (Eds). WHO classification of tumors: Pathology and genetics of tumours of haematopoietic and lymphoid tissues (2001), IARC Press, Lyon 244-253
2. Eshoa C., Perkins S., Kampalath B., Shidham V., Juckett M., and Chang C.C. Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas. Am. J. Clin. Pathol. 115 (2001) 862-867
3. Bohen S.P., Troyanskaya O.G., Alter O., Warnke R., Botstein D., Brown P.O., and Levy R. Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc. Natl. Acad. Sci. USA 100 (2003) 1926-1930
4. Ek S., Bjorck E., Hogerkorp C.M., Nordenskjold M., Porwit-MacDonald A., and Borrebaeck C.A. Mantle cell lymphomas acquire increased expression of CCL4, CCL5 and 4-1BB-L implicated in cell survival. Int. J. Cancer 118 (2006) 2092-2097
5. Kuppers R. Prognosis in follicular lymphoma-its in the microenvironment. N. Engl. J. Med. 351 (2004) 2152-2153
6. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 (1997) 521-530
7. Nishimura M., Umehara H., Nakayama T., Yoneda O., Hieshima K., Kakizaki M., Dohmae N., Yoshie O., and Imai T. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168 (2002) 6173-6180
8. Andre F., Cabioglu N., Assi H., Sabourin J.C., Delaloge S., Sahin A., Broglio K., Spano J.P., Combadiere C., Bucana C., Soria J.C., and Cristofanilli M. Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer. Ann. Oncol. 17 (2006) 945-951
9. Shulby S.A., Dolloff N.G., Stearns M.E., Meucci O., and Fatatis A. CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res. 64 (2004) 4693-4698
10. Pascual V., Liu Y.J., and Banchereau J. Normal human B cell sub-populations and their malignant counterparts. Baillieres Clin. Haematol. 10 (1997) 525-538
11. Ek S., Hogerkorp C.M., Dictor M., Ehinger M., and Borrebaeck C.A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res. 62 (2002) 4398-4405
12. Park C.C., Bissell M.J., and Barcellos-Hoff M.H. The influence of the microenvironment on the malignant phenotype. Mol. Med. Today 6 (2000) 324-329
13. Chouaib S., Thiery J., Gati A., Guerra N., El Behi M., Dorothee G., Mami-Chouaib F., Bellet D., and Caignard A. Tumor escape from killing: role of killer inhibitory receptors and acquisition of tumor resistance to cell death. Tissue Antigens 60 (2002) 273-281
14. Hintzen R.Q., Lens S.M., Lammers K., Kuiper H., Beckmann M.P., and van Lier R.A. Engagement of CD27 with its ligand CD70 provides a second signal for T cell activation. J. Immunol. 154 (1995) 2612-2623
15. Tesselaar K., Xiao Y., Arens R., van Schijndel G.M., Schuurhuis D.H., Mebius R.E., Borst J., and van Lier R.A. Expression of the murine CD27 ligand CD70 in vitro and in vivo. J. Immunol. 170 (2003) 33-40
16. Mainou-Fowler T., Proctor S.J., Miller S., and Dickinson A.M. Expression and production of interleukin 4 in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma 42 (2001) 689-698
17. Ferrer A., Ollila J., Tobin G., Nagy B., Thunberg U., Aalto Y., Vihinen M., Vilpo J., Rosenquist R., and Knuutila S. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia. Cancer Genet. Cytogenet. 153 (2004) 69-72
18. Gasser O., Missiou A., Eken C., and Hess C. Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation. Blood 106 (2005) 3718-3724
19. Hatori K., Nagai A., Heisel R., Ryu J.K., and Kim S.U. Fractalkine and fractalkine receptors in human neurons and glial cells. J. Neurosci. Res. 69 (2002) 418-426